Parthanatos and its associated components: Promising therapeutic targets for cancer
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 163, 105299
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 124 references indexed in Scilit:
- Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progressionJournal of Experimental Medicine, 2012
- Apoptosis-Inducing Factor: Structure, Function, and Redox RegulationAntioxidants & Redox Signaling, 2011
- Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1–Dependent Cell Death (Parthanatos)Science Signaling, 2011
- Synthetic lethal targeting of PTEN mutant cells with PARP inhibitorsEMBO Molecular Medicine, 2009
- Redox-Linked Conformational Dynamics in Apoptosis-Inducing FactorJournal of Molecular Biology, 2009
- Deficiency in Poly(ADP-ribose) Polymerase-1 (PARP-1) Accelerates Aging and Spontaneous Carcinogenesis in MiceCurrent Gerontology and Geriatrics Research, 2008
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007
- Poly(ADP-ribose) (PAR) polymer is a death signalProceedings of the National Academy of Sciences, 2006
- Dissociating the dual roles of apoptosis‐inducing factor in maintaining mitochondrial structure and apoptosisThe EMBO Journal, 2006
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature Cell Biology, 2000